China vs Türkiye: HIV-positive TB patients on ART (antiretroviral therapy)
China
85.0%
in 2024
Türkiye
85.0%
in 2024
China rank
106th
Türkiye rank
106th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- China
- Türkiye
How they compare
China currently reports 85.0% against 85.0% in Türkiye, a difference of 0.0%.
The two have swapped places 6 times across 13 shared years of data; in 2010 it was Türkiye ahead.
China ranks 106th and Türkiye ranks 106th of 144 countries.
Across the 2 decades both report, China averaged higher in 1 and Türkiye in 1.
Head to head by decade
| Decade | China | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 63.0% | 77.9% | 14.9% | Türkiye |
| 2020s | 81.2% | 79.2% | 2.0% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), China or Türkiye?
- China, at 85.0% against 85.0% in Türkiye as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between China and Türkiye?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Türkiye?
- 13 years are reported by both, from 2010 to 2024.
- How do China and Türkiye rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- China ranks 106th and Türkiye ranks 106th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.